Fundación Pública Andaluza para la gestión de la Investigación en Sevilla: Infections trials
The registry lists 13 Infections studies with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 3 5No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Antimicrobial Durations Treatment of Infections Associated With Osteosynthesis MaterialRecruitingNCT05294796Phase 3
- Negative Pressure Therapy After Infected Mesh Removal.Status unknownNCT05247086Not applicable
- Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical PatientsStatus unknownNCT04257812
- Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.Status unknownNCT04076436
- Study to Optimize the Use of New AntibioticsStatus unknownNCT03941951Not applicable
- ARTHR-IS (Arthroplasties' Infections Due to Staphylococcus Aureus)Status unknownNCT03826108
- Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective EndocarditisCompletedNCT03681431Phase 2
- European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to CarbapenemsCompletedNCT02709408
- Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill PatientsCompletedNCT02408185Phase 1
- Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by EnterobacteriaceaeCompletedNCT02400268Phase 3
- Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.ColiCompletedNCT02142751Phase 3
- "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".TerminatedNCT01761201Phase 3
- Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas AeruginosaCompletedNCT01577368Phase 3